ADTX Aditxt Inc. Accounting Capitalization
Aditxt (ADTX) success relies on the demand for precision diagnostics and an influx of growth investments. The company is currently undergoing a complex restructuring due to IT service debts, which temporarily complicates engagements with external contractors. Meanwhile, the business is developing digital systems for biomaterial analysis to accelerate testing. The metric value is -867.32, and this price chart clearly illustrates the asset's dynamics.
%20Company%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvouo2ve.rkk-7albim8&start=20220704&end=20261026&filename=GURU_Markets_-_ADTX_-_Aditxt_-_Company-Book-Value "Aditxt Corp (ADTX): Net Asset Value from 07/04/2022 to 07/11/2026 | 👁️GURU.Markets👁️")
Metric breakdowns and analytics for Aditxt Corp (ADTX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:ADTX - Aditxt, Inc.
Book value capitalization measures the total value of Aditxt (ADTX) net assets minus all liabilities, determining the actual intrinsic value of the business. Monitoring book value trends reflects capital sensitivity to financial reporting, which is critical for assessing the financial stability of high-tech IT platforms for health profiling and immune monitoring systems that ensure organ transplant safety.
Competitor analysis for Aditxt
argenx BVBA (ARGX) - Total Net Assets|Company Net Assets BioNTech SE|ABVX (ABIVAX) - Accounting Capitalization|Company Book Value ADMA Biologics, Inc. ADMA|Net Asset Value Protagonist Therapeutics, Inc.|Immunovant Corp (IMVT) - Book Capitalization|Accounting Value of Company Kiniksa Corp (KNSA)|Book Capitalization GRFS (Grifols, S.A.)|adaptivebiotech.com - Book Capitalization|Company Book Value Celldex Therapeutics, Inc. (CLDX)|AUPH: Accounting Value of Company|BCRX (BioCryst Pharmaceuticals Inc) - Company Book Value|Vera Corp (VERA) - Company Net Assets|DNTH (Dianthus Therapeutics) - Book Capitalization|Book Capitalization pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Company Net Assets|Accounting Value of Company Tourmaline Bio Inc (TRML)|Book Capitalization PGEN|Pharming Corp - Book Valuation of Business|NKTR: Company Book Value|UPB: Company Net Assets|ZBIO (Zenas Biopharma) - Company Book Value|Company Net Assets Immunome Inc|GOSS (Gossamer Corp) - Company Net Assets|Book Capitalization KALV|Company Book Value Septerna Inc SEPN|Accounting Capitalization pieris.com (PVLA)|SVRA: Book Capitalization|Total Stockholders' Equity Rigel Pharma RIGL|AnaptysBio Corp - Book Capitalization|ATXS - Book Capitalization|Book Capitalization enGene Holdings Inc.|rapt.com (RAPT) - Accounting Capitalization|JBIO: Book Capitalization|Book Valuation of Business Aclaris Therapeutics Inc. (ACRS)|Company Net Assets Kyverna|Total Net Assets Tiziana Life Sciences, Ltd. TLSA|CABA - Company Net Assets|VTYX - Accounting Capitalization|Company Net Assets Theratechnologies THTX|AVTX - Total Net Assets|ELDN: Book Capitalization|Agenus, Inc (AGEN) - Book Capitalization|Book Capitalization Climb Bio Inc (CLYM)|Accounting Capitalization zurabio.com (ZURA)|Company Net Assets aTyr Pharma|Total Net Assets adagene.com ADAG|IMA - Company Net Assets|Shattuck Labs Inc - Accounting Capitalization|Company Book Value Equillium Bio|CNTB - Net Asset Value|Book Capitalization immunic-therapeutics.com IMUX|Atara Bio (ATRA) - Accounting Value of Company|IFRX (InflaRx NV) - Book Capitalization|Book Capitalization XFOR|Adicet Bio (ACET) - Company Book Value|Accounting Value of Company CELU (celularity.com)|INmune Bio - Company Book Value|Company Net Assets Barinthus Biotherapeutics PLC BRNS|Kezar Life Sciences, Inc - Book Capitalization|SAB Biotherapeutics Inc (SABS) - Book Capitalization|Company Net Assets Akari Therapeutics AKTX|Enlivex Therapeutics Ltd. (ENLV) - Accounting Value of Company|QTTB: Book Capitalization|Book Valuation of Business GOVX|Company Book Value EDSA (Edesa)|Company Net Assets IBIO (iBio Corporation)|Carisma Therapeutics Inc. - Company Book Value|XTLB - Company Net Assets|Bolt Bio - Company Net Assets|HCWB: Book Capitalization|Company Book Value aptevotherapeutics.com|aimimmuno.com (AIM) - Accounting Capitalization|Book Capitalization GRI (GRI Bio, Inc.)|Total Stockholders' Equity xortx.com|Book Capitalization HIND|Book Capitalization Revelation Biosciences Inc (REVB)|INDP - Book Capitalization|Accounting Capitalization BiondVax Pharmaceuticals SCNI|Book Capitalization CALI (CalciMedica Corp)|Affimed (AFMD) - Book Valuation of Business|ALLK - Company Net Assets|Total Net Assets HOOKIPA Pharma|Company Net Assets IGM Biosciences Inc. (IGMS)|Accounting Capitalization iTeos Pharma (ITOS)|Company Net Assets Ocean Biomedical, Inc.|Total Net Assets tcbiopharm.com (TCBP)|Book Capitalization THRD (Third Harmonic Bio, Inc.)